Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Centessa Pharmaceuticals Announced Poster Presentation of First Preclinical Data for LockBody Program at ASCO

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage pharmaceutical company with a Research & Development ("R&D") innovation engine that aims to discover, develop and ultimately deliver impactful medicines to patients, today announced presentation of the first preclinical data for LB101, PD-L1xCD47 LockBody, in a post

CNTA